![Michael Lars Sjöström](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Michael Lars Sjöström
Fondateur chez
Sectoral Asset Management Inc (Private Equity)
Profil
Michael Lars J.
Sjöström is the founder of Sectoral Asset Management, Inc., founded in 2000, where the title held is Partner.
Mr. Sjöström was the founder of Sectoral Asset Management, Inc. (Switzerland), founded in 2005, where the title held was Chief Executive Officer.
Mr. Sjöström is the founder of Sectoral Asset Management Inc (Private Equity), founded in 2000, where the title held is Partner.
Mr. Sjöström currently holds the position of Director at CurvaFix, Inc. Mr. Sjöström currently holds the position of Director at Abcdx SA. Former positions include Director at eFFECTOR Therapeutics Operations, Inc., Director at Shockwave Medical, Inc., and Portfolio Manager at Banque Pictet & Cie SA from 1993 to 2000.
Education includes an MBA degree from the University of St. Gallen, conferred in 1987.
Postes actifs de Michael Lars Sjöström
| Sociétés | Poste | Début |
|---|---|---|
Sectoral Asset Management Inc (Private Equity)
 Sectoral Asset Management Inc (Private Equity) Investment ManagersFinance Sectoral Asset Management invests in companies located in North America and Europe. The firm focuses on biotechnology, medtech and life sciences sectors. It provides financing for late stage capital requirements. | Fondateur | 01/09/2000 |
Sectoral Asset Management, Inc.
 Sectoral Asset Management, Inc. Investment ManagersFinance Sectoral aims to achieve superior returns for their investors by concentrating on primary research of company fundamentals and in-depth due diligence on companies to assess their scientific, business, financial and ESG aspects. The firm offers four Healthcare strategies: Global Healthcare, Emerging Healthcare, Small & Mid-Cap Healthcare & Biotech. They employ a bottom-up investment approach that can be categorized as Growth at a Reasonable Price (GARP). | Fondateur | 01/01/2000 |
Abcdx SA
 Abcdx SA Medical SpecialtiesHealth Technology Develops and manufactures diagnostic tools transforming care for patients with brain injuries | Directeur/Membre du Conseil | - |
CurvaFix, Inc.
 CurvaFix, Inc. Medical SpecialtiesHealth Technology Manufactures and markets emerging medical devices | Directeur/Membre du Conseil | - |
Anciens postes connus de Michael Lars Sjöström
| Sociétés | Poste | Fin |
|---|---|---|
Banque Pictet & Cie SA
 Banque Pictet & Cie SA Investment ManagersFinance Banque Pictet & Cie constructs portfolios of investments in large companies with stable earnings, balanced by shorter-term positions in stocks that have been mispriced or have the potential for recovery for bonds and equities. The fixed-income component generally includes core holdings of investment-grade sovereign debt and corporate bonds, complemented by opportunistic investments in high-yield corporate bonds and local currency emerging-market debt. Their fund mandates are managed by the team responsible for discretionary portfolios of mutual funds, exchange-traded funds and other pooled vehicles, operating on the principle of open architecture, selecting best-in-class Pictet or external funds. The firm also offers special mandates, such as absolute return mandates. | Corporate Officer/Principal | 30/10/2000 |
eFFECTOR Therapeutics Operations, Inc.
 eFFECTOR Therapeutics Operations, Inc. BiotechnologyHealth Technology Operates a clinical-stage biopharmaceutical company that develops oncology drugs | Directeur/Membre du Conseil | - |
| SHOCKWAVE MEDICAL | Directeur/Membre du Conseil | - |
Sectoral Asset Management, Inc. (Switzerland)
 Sectoral Asset Management, Inc. (Switzerland) Investment ManagersFinance Sectoral is a fundamentals-based, medium- to long-term, GARP-oriented manager which focuses on companies in the healthcare (Pharmaceuticals, Generics, Biotechs and Medtechs) sector. They aim to achieve superior returns for investors by concentrating on primary research. The firm conducts preliminary research and analysis, including literature and documentation, interaction with companies and with Sectoral's Advisory Network, to identify investment candidates. They then conduct forecasting and scenario analyses, testing a range of assumptions and success factors critical to the company's success. They subsequently generate realistic valuation ranges for potential investments and assess the impact of the investment on the overall risk/return profile of the portfolio. They believe that specific risk is the most important risk component and have developed and refined their investment process to mitigate it. Their analysts attempt to determine the fair value for investment candidates as well as 1-year and 3-year price targets. Depending on the development stage of the company, they utilize models such as discounted cash-flow models, EBITDA models, classical growth models (PE approach), enterprise value/sales and peer group analysis to determine the price targets. Sectoral makes recommendations based on the resulting fair value to the current market value of each investment candidate and constructs portfolios comprised of analysts' investment recommendations. Their CIO determines the weight of each industry based on the attractiveness of expected growth, profitability, historic valuation and relative valuation. | Fondateur | - |
Formation de Michael Lars Sjöström
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
65
Relations au 1er degré
9
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 9 |
|---|---|
Banque Pictet & Cie SA
Banque Pictet & Cie SA Investment ManagersFinance Banque Pictet & Cie constructs portfolios of investments in large companies with stable earnings, balanced by shorter-term positions in stocks that have been mispriced or have the potential for recovery for bonds and equities. The fixed-income component generally includes core holdings of investment-grade sovereign debt and corporate bonds, complemented by opportunistic investments in high-yield corporate bonds and local currency emerging-market debt. Their fund mandates are managed by the team responsible for discretionary portfolios of mutual funds, exchange-traded funds and other pooled vehicles, operating on the principle of open architecture, selecting best-in-class Pictet or external funds. The firm also offers special mandates, such as absolute return mandates. | Finance |
Sectoral Asset Management, Inc.
Sectoral Asset Management, Inc. Investment ManagersFinance Sectoral aims to achieve superior returns for their investors by concentrating on primary research of company fundamentals and in-depth due diligence on companies to assess their scientific, business, financial and ESG aspects. The firm offers four Healthcare strategies: Global Healthcare, Emerging Healthcare, Small & Mid-Cap Healthcare & Biotech. They employ a bottom-up investment approach that can be categorized as Growth at a Reasonable Price (GARP). | Finance |
University of St. Gallen
 University of St. Gallen Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Sectoral Asset Management, Inc. (Switzerland)
Sectoral Asset Management, Inc. (Switzerland) Investment ManagersFinance Sectoral is a fundamentals-based, medium- to long-term, GARP-oriented manager which focuses on companies in the healthcare (Pharmaceuticals, Generics, Biotechs and Medtechs) sector. They aim to achieve superior returns for investors by concentrating on primary research. The firm conducts preliminary research and analysis, including literature and documentation, interaction with companies and with Sectoral's Advisory Network, to identify investment candidates. They then conduct forecasting and scenario analyses, testing a range of assumptions and success factors critical to the company's success. They subsequently generate realistic valuation ranges for potential investments and assess the impact of the investment on the overall risk/return profile of the portfolio. They believe that specific risk is the most important risk component and have developed and refined their investment process to mitigate it. Their analysts attempt to determine the fair value for investment candidates as well as 1-year and 3-year price targets. Depending on the development stage of the company, they utilize models such as discounted cash-flow models, EBITDA models, classical growth models (PE approach), enterprise value/sales and peer group analysis to determine the price targets. Sectoral makes recommendations based on the resulting fair value to the current market value of each investment candidate and constructs portfolios comprised of analysts' investment recommendations. Their CIO determines the weight of each industry based on the attractiveness of expected growth, profitability, historic valuation and relative valuation. | Finance |
eFFECTOR Therapeutics Operations, Inc.
eFFECTOR Therapeutics Operations, Inc. BiotechnologyHealth Technology Operates a clinical-stage biopharmaceutical company that develops oncology drugs | Health Technology |
Shockwave Medical, Inc.
 Shockwave Medical, Inc. Medical SpecialtiesHealth Technology Develops intravascular devices for calcified cardiovascular disease | Health Technology |
Sectoral Asset Management Inc (Private Equity)
Sectoral Asset Management Inc (Private Equity) Investment ManagersFinance Sectoral Asset Management invests in companies located in North America and Europe. The firm focuses on biotechnology, medtech and life sciences sectors. It provides financing for late stage capital requirements. | Finance |
CurvaFix, Inc.
CurvaFix, Inc. Medical SpecialtiesHealth Technology Manufactures and markets emerging medical devices | Health Technology |
Abcdx SA
Abcdx SA Medical SpecialtiesHealth Technology Develops and manufactures diagnostic tools transforming care for patients with brain injuries | Health Technology |
